Gain Therapeutics, Inc. (GANX) Weighted Average Number of Shares Outstanding, Basic 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Gain Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2020 to 2024.
  • Gain Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending March 31, 2024 was 18 M shares, a 50.6% increase year-over-year.
  • Gain Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 13 M shares, a 9.49% increase from 2022.
  • Gain Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 11.9 M shares, a 16.9% increase from 2021.
  • Gain Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 10.2 M shares, a 279% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 18 M +6.04 M +50.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 13 M +1.13 M +9.49% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 12.7 M +818 K +6.88% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 12.4 M +504 K +4.24% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 11.9 M +51.7 K +0.44% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 11.9 M +1.72 M +16.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 11.9 M +6.62 K +0.06% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 11.9 M +6.91 K +0.06% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 11.9 M +7.01 M +144% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 10.2 M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 11.9 M +8.67 M +271% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 11.9 M +9.89 M +499% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 4.87 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 3.2 M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 1.98 M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.